Bain Capital vs ICONIQ

Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Third Quarter Ended September 30, 2026

Bain Capital Specialty Finance, Inc. has scheduled its earnings release for the third quarter ended September 30, 2026, announced on October 26, 2026.

Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the Third Quarter Ended September 30, 2026

Bain Capital Specialty Finance, Inc. has scheduled its earnings release for the third quarter ended September 30, 2026.

FundPark Secures Up to US$250 Million from Bain Capital to Support Its Next Phase of Growth

Bain Capital Special Situations announces a US$250 million investment in FundPark, a fintech platform, to support its growth.

Anthropic backers' stakes worth billions before IPO

As Anthropic prepares for a potential IPO at a valuation of up to $2 trillion, various early and late-stage investors are sitting on substantial paper gains based on the company's latest private valuation of $965 billion. The report, according to Bloomberg, highlights stakes held by notable backers. Eric Schmidt, who invested in Anthropic's Series A in 2021, now owns about 1% worth nearly $10 billion. Iconiq invested $6 billion last year, a stake now valued at $17 billion. Menlo Ventures has invested over $1 billion, now worth $14 billion. Sequoia made a $3 billion investment earlier this year, already doubled. Sound Ventures, founded by Ashton Kutcher, invested a total of $435 million, resulting in a stake worth billions. Spark Capital, holding a board seat, invested $75 million in a Series C round, now worth $7 billion.

• Anthropic is expected to go public this year at a valuation of up to $2 trillion.
• Anthropic's latest private valuation is $965 billion.
• Eric Schmidt's stake is worth nearly $10 billion.

Anthropic Cap Table: VCs Late to IPO Party, None Own Over 2%

A detailed report on Anthropic's cap table reveals that despite the company's upcoming IPO, venture capital firms were late investors. Iconiq, Menlo, and Lightspeed are set to be the biggest venture winners, yet none hold more than 2% of the company. Anthropic deliberately structured its funding to keep individual investor stakes below this level, ensuring no single VC had outsized control. The article paints a messy picture of Anthropic's rise from a small OpenAI defector group to a juggernaut, with many VCs initially passing due to its unusual structure and safety focus. This strategic approach to its cap table highlights the company's unique governance and investor diversification.

• Anthropic is set for a potential IPO next month, likely the largest of all time.
• No venture capital firm owns more than 2% of Anthropic.
• Iconiq, Menlo, and Lightspeed are the biggest venture winners in the upcoming IPO.

Enveda raises $311M for AI drug discovery

Enveda, an AI-driven biotech startup focused on discovering drugs from natural sources, has raised $311 million in a Series E funding round at a $2 billion valuation. The round was led by Catalio Capital Management, with participation from Iconiq and others, doubling the company's valuation from 12 months ago. Enveda, founded in 2019 by Viswa Colluru, uses AI to accelerate the discovery of drugs from plants and microbes. The startup is currently advancing several drug candidates into clinical trials, including treatments for severe skin conditions and a drug designed to maintain weight loss after discontinuation of GLP-1s. This funding will support further clinical development.

• Enveda raised $311 million in Series E funding at a $2 billion valuation.
• Catalio Capital Management led the round, with participation from Iconiq and others.
• The new valuation doubles Enveda's valuation from 12 months ago.